-2.jpg)
C&B Minicast
Welcome to the Cognitive & Behavioral Health Center of Charleston’s podcast channel!
Our Minicasts offer insightful, bite-sized episodes led by our experienced directors. From discussions on trauma and mental health awareness to topics on community well-being, our episodes provide valuable information and practical tips. Tune in for quick, thought-provoking content aimed at fostering better mental health and a stronger community.
C&B Minicast
Can Psychedelics Change the Future of Mental Health Treatment?
Can psychedelics change the future of mental health treatment? In this episode, we provide an overview of psychedelic research over the past five years. Studies on psilocybin, MDMA, ketamine and esketamine are discussed. Curious about participating in a trial? Visit ClinicalTrials.gov.
#CBHealthCharleston #MentalHealthAwareness #PsychedelicResearch #KetamineTherapy #PsilocybinHealing #MDMAWellness #ClinicalTrials
American
Psychiatric Association. (2022). Position
statement on the use of psychedelic and empathogenic agents for mental health conditions.
American Psychiatric Association.
https://www.psychiatry.org/
Bogenschutz,
M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., ... & Khalsa, S. S. (2022). Percentage of heavy drinking days following psilocybin-assisted treatment for alcohol use disorder: A randomized clinical trial.
JAMA
Psychiatry, 79(10),
953–962.
https://doi.org/10.1001/jamapsychiatry.2022.2096
Carhart-Harris,
R. L., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression.
New
England Journal of Medicine, 384(15),
1402–1411.
https://doi.org/10.1056/NEJMoa2032994
Daly,
E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., ... & Drevets, W. C. (2019). Efficacy of esketamine nasal spray plus oral antidepressant vs antidepressant plus placebo for relapse prevention in treatment-resistant depression: A randomized clinical
trial. JAMA
Psychiatry, 76(9),
893–903.
https://doi.org/10.1001/jamapsychiatry.2019.1189
Goodwin,
G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., ... & Wiegand, F. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression.
New
England Journal of Medicine, 387(18),
1637–1648.
https://doi.org/10.1056/NEJMoa2206443